Screening for Type II L-Asparaginases: Lessons from the Genus Halomonas
(ندگان)پدیدآور
Sharafi, ZeinabBarati, MahmoodKhoshayand, MohammadrezaAdrangi, Sinaنوع مدرک
TextResearch article
زبان مدرک
Englishچکیده
Among the two types of bacterial L-asparaginases, only type II enzymes have been used inthe treatment of acute lymphoblastic leukemia owing to their higher affinity for L-asparagine.However, current screening media used for the isolation of L-asparaginase-producingmicroorganisms do not discriminate between the two types of L-asparaginase. During anoptimization study conducted to increase L-asparaginase production by environmentalHalomonas isolates, it was noticed that the pattern of L-asparaginase production in responseto variations in glucose concentration varied between different isolates suggesting that theydiffer in their ability to produce type II L-asparaginases, an observation that was confirmed byfurther experiments. Bioinformatics analysis of available Halomonas whole genome sequencesrevealed that indeed some species of this genus possess both L-asparaginase types while otherspossess only type I enzymes. By comparing the growth pattern of these isolates on differentmedia, we propose that by omitting glucose, reducing the concentration of L-asparagine andproviding an alternative nitrogen source in L-asparaginase screening media it may be possibleto differentiate between type I and type II activities.
کلید واژگان
ScreeningL-asparaginase
Halomonas
Oligotrophy
optimization
Pharmacutical biotechnology
شماره نشریه
4تاریخ نشر
2017-11-011396-08-10
ناشر
School of Pharmacy, Shahid Beheshti University of Medical Sciencesسازمان پدید آورنده
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
شاپا
1735-03281726-6890




